Tasia Blazevich

Tasia serves as a leader in Deloitte & Touche LLP’s Capital Markets Transactions (CMT) group and co-leads the CMT Life Sciences industry offering, focusing on services related to transactions (IPOs, reverse mergers, SPACs), complex technical accounting, SEC reporting, financial statement reporting, and Sarbanes-Oxley implementation and compliance. She has more than 20 years of experience serving public and private companies in the life sciences, consumer products, aerospace and defense, and technology industries, and has spent the last 10 years focusing on emerging growth biotech and early-stage pharmaceutical companies.

Tasia is the San Diego market leader for the Accounting Advisory Services group, with a demonstrated track record of new business development and brand/market awareness. Prior to serving in this role, she focused on auditing emerging growth biotech and early-stage pharmaceutical companies in the San Diego market, and prior to that, worked in the private sector in various SEC reporting and technical accounting roles.